Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.

[1]  C. A. Baptista,et al.  Depression levels in chronic orofacial pain patients: a pilot study. , 2004, Journal of oral rehabilitation.

[2]  M. Vitti,et al.  Electromyographic evaluation of masseter and anterior temporalis muscles in patients with temporomandibular disorders following interocclusal appliance treatment. , 2004, Journal of oral rehabilitation.

[3]  Ronald Attanasio.  Management of Temporomandibular Disorders and Occlusion , 2003 .

[4]  J. V. von Lindern,et al.  Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  M. Schwartz,et al.  Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. , 2003, The journal of pain : official journal of the American Pain Society.

[6]  M. Schwartz,et al.  Treatment of Temporomandibular Disorders with Botulinum Toxin , 2002, The Clinical journal of pain.

[7]  P. Major,et al.  Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain , 2002, Pain.

[8]  P. Conti,et al.  Pain measurement in TMD patients: evaluation of precision and sensitivity of different scales. , 2001, Journal of oral rehabilitation.

[9]  W. King,et al.  A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. , 2001, British journal of plastic surgery.

[10]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[11]  A. Perron,et al.  Clinical utility of surface EMG: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology , 2000, Neurology.

[12]  M. Schwartz,et al.  Botulinum toxin: new treatment for temporomandibular disorders. , 2000, The British journal of oral & maxillofacial surgery.

[13]  MD D.S. Goodin,et al.  Clinical utility of surface EMG , 2000, Neurology.

[14]  J. Jankovic,et al.  Treating severe bruxism with botulinum toxin. , 2000, Journal of the American Dental Association.

[15]  G. Clark.  The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findings , 1999 .

[16]  M. Schwartz,et al.  The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  G. Deuschl,et al.  What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport® , 1998, Journal of neurology, neurosurgery, and psychiatry.

[18]  S. Davies,et al.  The pattern of splint usage in the management of two common temporomandibular disorders. Part II: The stabilisation splint in the treatment of pain dysfunction syndrome , 1997, British Dental Journal.

[19]  S. Dworkin.  A Model for Pain Mechanisms in Myogenous Temporomandibular Disorders , 1997 .

[20]  H. Abekura,et al.  Asymmetry of masticatory muscle activity during intercuspal maximal clenching in healthy subjects and subjects with stomatognathic dysfunction syndrome. , 1995, Journal of oral rehabilitation.

[21]  S. Kopp,et al.  The effects of an occlusal splint on the electromyographic activities of the temporal and masseter muscles during maximal clenching in patients with a habit of nocturnal bruxism and signs and symptoms of craniomandibular disorders. , 1990, Journal of oral rehabilitation.

[22]  J. P. Lund,et al.  Devices for the diagnosis and treatment of temporomandibular disorders. Part II: Electromyography and sonography. , 1990, The Journal of prosthetic dentistry.

[23]  A. Watkinson.  The mandibular rest position and electromyography--a review. , 1987, Journal of oral rehabilitation.

[24]  L. V. Christensen,et al.  Mandibular reference positions. , 1985, Journal of oral rehabilitation.

[25]  R. Miralles,et al.  The changes in electrical activity of the postural muscles of the mandible upon varying the vertical dimension. , 1981, The Journal of prosthetic dentistry.

[26]  A. Blitzer,et al.  Noncosmetic uses of botulinum toxin. , 2004, Clinics in dermatology.

[27]  L. Leresche.  Assessment of physical and behavioral outcomes of treatment. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[28]  B. C. Cooper,et al.  The role of bioelectronic instrumentation in the documentation and management of temporomandibular disorders. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[29]  J. Okeson.  Orofacial pain : guidelines for assessment, diagnosis, and management , 1996 .

[30]  P. Koidis,et al.  Effectiveness of conservative treatment for craniomandibular disorders: a 2-year longitudinal study. , 1994, Journal of orofacial pain.

[31]  S. Dworkin,et al.  Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. , 1992, Journal of craniomandibular disorders : facial & oral pain.

[32]  Lund Jp,et al.  Evaluation of the use of surface electromyography in the diagnosis, documentation, and treatment of dental patients. , 1989 .

[33]  J. Okeson.  Management of Temporomandibular Disorders and Occlusion , 1989 .